CNS Pharmaceuticals Inc. (NASDAQ: CNSP) stock closed at 2.1 per share at the end of the most recent trading day (a -0.94% change compared to the prior day closing price) with a volume of 46.19K shares and market capitalization of 11.02M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 3 people. CNS Pharmaceuticals Inc. CEO is John M Climaco.

The one-year performance of CNS Pharmaceuticals Inc. stock is -15.54%, while year-to-date (YTD) performance is -12.5%. CNSP stock has a five-year performance of %. Its 52-week range is between 0.6105 and 4.4, which gives CNSP stock a 52-week price range ratio of 39.31%

CNS Pharmaceuticals Inc. currently has a PE ratio of -0.30, a price-to-book (PB) ratio of 0.46, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of -, a ROA of -118.84%, a ROC of -142.89% and a ROE of -143.65%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from CNS Pharmaceuticals Inc., there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. CNS Pharmaceuticals Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for CNS Pharmaceuticals Inc. is Hold (3), with a target price of $5.5, which is +161.91% compared to the current price. The earnings rating for CNS Pharmaceuticals Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

CNS Pharmaceuticals Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

CNS Pharmaceuticals Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 23.97, ATR14 : 0.25, CCI20 : 32.38, Chaikin Money Flow : -0.10, MACD : 0.10, Money Flow Index : 72.84, ROC : 0.95, RSI : 52.85, STOCH (14,3) : 41.13, STOCH RSI : 0.18, UO : 45.91, Williams %R : -58.87), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of CNS Pharmaceuticals Inc. in the last 12-months were: Christopher Downs (Buy at a value of $9 920), Climaco John (Buy at a value of $4 950), Downs Christopher (Buy at a value of $9 920), Downs Christopher (Sold 0 shares of value $0 ), Jerzy George Gumulka (Buy at a value of $9 558), Jerzy Gumulka (Buy at a value of $9 558), John M. Climaco (Buy at a value of $10 409), Waldemar Priebe (Sold 88 798 shares of value $119 529 )